IL155078A0 - A process for hydrogenating steroid alkenes - Google Patents

A process for hydrogenating steroid alkenes

Info

Publication number
IL155078A0
IL155078A0 IL15507801A IL15507801A IL155078A0 IL 155078 A0 IL155078 A0 IL 155078A0 IL 15507801 A IL15507801 A IL 15507801A IL 15507801 A IL15507801 A IL 15507801A IL 155078 A0 IL155078 A0 IL 155078A0
Authority
IL
Israel
Prior art keywords
hydrogenating
compounds
ammonium
alkenes
steroid
Prior art date
Application number
IL15507801A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL155078A0 publication Critical patent/IL155078A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Valve Device For Special Equipments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15507801A 2000-11-03 2001-11-02 A process for hydrogenating steroid alkenes IL155078A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0026876.3A GB0026876D0 (en) 2000-11-03 2000-11-03 Process
PCT/US2001/048173 WO2002046207A2 (en) 2000-11-03 2001-11-02 Process

Publications (1)

Publication Number Publication Date
IL155078A0 true IL155078A0 (en) 2003-10-31

Family

ID=9902484

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15507801A IL155078A0 (en) 2000-11-03 2001-11-02 A process for hydrogenating steroid alkenes
IL155078A IL155078A (en) 2000-11-03 2003-03-25 Process for the hydrogenation of alkene steroids

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155078A IL155078A (en) 2000-11-03 2003-03-25 Process for the hydrogenation of alkene steroids

Country Status (24)

Country Link
US (1) US6794508B2 (de)
EP (1) EP1335930B1 (de)
JP (1) JP4257117B2 (de)
KR (1) KR100821018B1 (de)
CN (1) CN1313480C (de)
AT (1) ATE279429T1 (de)
AU (2) AU2002241624B2 (de)
BR (1) BR0115089A (de)
CA (1) CA2427709A1 (de)
DE (1) DE60106482T2 (de)
DK (1) DK1335930T3 (de)
ES (1) ES2230383T3 (de)
GB (1) GB0026876D0 (de)
HK (1) HK1058799A1 (de)
HU (1) HUP0303907A3 (de)
IL (2) IL155078A0 (de)
MX (1) MXPA03003925A (de)
NO (1) NO325180B1 (de)
NZ (1) NZ525168A (de)
PL (1) PL206539B1 (de)
PT (1) PT1335930E (de)
SI (1) SI1335930T1 (de)
WO (1) WO2002046207A2 (de)
ZA (1) ZA200302560B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503193B1 (ko) 2002-08-19 2005-07-25 한미약품 주식회사 3-옥소-4-아자-5α-안드로스탄 화합물의 선택적인 제조방법
WO2005075497A1 (en) * 2004-01-07 2005-08-18 Ranbaxy Laboratories Limited PROCESS FOR THE PREPARATION OF 17ß-SUBSTITUTED-3-OXO-4-AZA-5ALPHA-ANDROSTANE DERIVATIVES
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法
AR070313A1 (es) * 2008-01-03 2010-03-31 Gador Sa Un procedimiento para preparar una forma solida y cristalina de dutasteride, una forma polimorfica del compuesto (forma iii) y una composicion farmaceutica que incluye dicha forma
HU230730B1 (hu) 2011-06-30 2017-12-28 Richter Gedeon Nyrt Eljárás (5alfa,17béta)-N-[2,5-bisz-(trifluormetil)-fenil]-3-oxo-4-aza-5-androszt-1-én-17-karbonsavamid előállítására
CN103059097A (zh) * 2011-10-20 2013-04-24 连云港润众制药有限公司 一种度他雄胺中间体的制备方法
CN103254268A (zh) * 2013-05-16 2013-08-21 寿光市富康化学工业有限公司 一种制备度他雄胺的工艺
CN104231033B (zh) * 2014-09-17 2016-08-24 广东众生药业股份有限公司 一种度他雄胺的制备方法
CN108051513B (zh) * 2017-11-27 2020-09-29 重庆华邦制药有限公司 Hplc法分离测定度他雄胺起始原料sm2及其相关杂质的方法
CN109438549B (zh) * 2018-12-13 2022-01-04 湖北葛店人福药业有限责任公司 一种制备N-叔丁基-3-氧代-4-氮杂-5α-雄甾-17β-甲酰胺的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211145A (en) 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB2264494A (en) 1992-02-25 1993-09-01 Merck & Co Inc 17b-n-monosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-1-en-3-one testosterone-5-alpha reductase inhibitors
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones

Also Published As

Publication number Publication date
WO2002046207A3 (en) 2003-03-20
KR100821018B1 (ko) 2008-04-08
WO2002046207A2 (en) 2002-06-13
JP4257117B2 (ja) 2009-04-22
ATE279429T1 (de) 2004-10-15
KR20030081326A (ko) 2003-10-17
DE60106482T2 (de) 2005-10-13
NO20031995D0 (no) 2003-05-02
HK1058799A1 (en) 2004-06-04
EP1335930A2 (de) 2003-08-20
PL206539B1 (pl) 2010-08-31
PL365705A1 (en) 2005-01-10
CN1473165A (zh) 2004-02-04
AU4162402A (en) 2002-06-18
ES2230383T3 (es) 2005-05-01
US6794508B2 (en) 2004-09-21
HUP0303907A3 (en) 2012-09-28
NO20031995L (no) 2003-05-02
BR0115089A (pt) 2003-10-07
EP1335930B1 (de) 2004-10-13
AU2002241624B2 (en) 2004-10-28
NZ525168A (en) 2005-03-24
IL155078A (en) 2009-06-15
HUP0303907A2 (hu) 2004-03-01
CN1313480C (zh) 2007-05-02
NO325180B1 (no) 2008-02-11
US20040049042A1 (en) 2004-03-11
SI1335930T1 (en) 2005-04-30
ZA200302560B (en) 2004-04-01
GB0026876D0 (en) 2000-12-20
PT1335930E (pt) 2005-01-31
MXPA03003925A (es) 2003-08-19
DK1335930T3 (da) 2005-02-14
CA2427709A1 (en) 2002-06-13
DE60106482D1 (de) 2004-11-18
JP2004515505A (ja) 2004-05-27

Similar Documents

Publication Publication Date Title
IL155078A0 (en) A process for hydrogenating steroid alkenes
BR0113670A (pt) Composição farmacêutica e método para tratar hipogonadismo
TW200512188A (en) Selective hydrogenation process and catalyst therefor
CA2420040A1 (en) New phenylalanine derivatives
MY131522A (en) PHARMACEUTICAL COMPOSITION AND USES FOR ANDROST-5-ENE-3ß,17ß-DIOL
PT1086745E (pt) Catalisadores de leito fixo
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
HUP0200173A3 (en) Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne
SI1347764T1 (sl) Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo
ES2147446T3 (es) Procedimiento de adicion de oro en dos etapas para preparar un catalizador del acetato de vinilo.
AU3694597A (en) Process for preparing alcohols and/or aldehydes from olefins
AU2001231849A1 (en) Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin
AU2002227970A1 (en) Method for producing cis-2-tert-butylcyclohexanol
WO2001097792A3 (en) Neuraminidase inhibitors in the treatment of equine influenza virus infection
DK0937094T3 (da) Fremgangsmåde til fremstilling af ivermectin
ES2220440T3 (es) Composicion disolvente medioambientalmente segura.
AU3699100A (en) Improved process for asymmetric hydrogenation
DE59910761D1 (de) Verfahren zur hydrierung von ungesättigten heterocyclischen verbindungen
HK1027057A1 (en) Preparation process of catalyst for producing alkenyl acetates and use of catalyst prepared by this process
GB957541A (en) 5ª‡-steroids